Drug Class
SGLT2 inhibitor
Type
brand
Active Ingredient
donanemab
📋Overview
Kisunla is a medication used in the management of Alzheimer's disease. It is designed to target and reduce amyloid plaques in the brain, which are associated with the progression of this neurodegenerative condition. Kisunla is part of a newer class of drugs that aim to address underlying disease mechanisms rather than just symptoms. Its use is generally associated with early stages of Alzheimer's disease.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Kisunla
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.